Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pazdurcanumab: US FDA’s Top Cancer Official Weighs In On That Big Neurology Approval
Jun 10 2021
•
By
Kate Rawson
OCE Director Richard Pazdur is part of the US FDA's brain trust on accelerated approval • Source: photo illustration/Alamy, FDA
More from Approval Standards
More from Pathways & Standards